Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabdosia rubescens dropping pills for prevention and treatment of radiation-induced oral mucositis in nasopharyngeal carcinoma
ChiCTR1800015210Phase 4Recruiting
- Sponsor
- Sichuan Cancer Hospital
- Start
- Jan 2018
- Countries
- 1
01
Overview
Phase 4, open-label trial of rabdosia rubescens in stomatitis and nasopharyngeal carcinoma (NPC), sponsored by Sichuan Cancer Hospital. Started Jan 2018; status: recruiting.
02
Drugs
rabdosia rubescens
03
Conditions
stomatitisnasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR1800015210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015210.